Quick Answer
Nanobiotix S.A. reported R&D Expense of $23.11 million for fiscal year 2025.
Nanobiotix S.A. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $23.11M | -43.0% |
| 2024 | $40.54M | +5.6% |
| 2023 | $38.40M | +17.6% |
| 2022 | $32.64M | +7.4% |
| 2021 | $30.38M | +24.9% |
| 2020 | $24.33M | -20.0% |
| 2019 | $30.41M | +45.6% |
| 2018 | $20.89M | — |
- Nanobiotix S.A. showed a decrease of -43.0% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2025 period, Nanobiotix S.A.’s r&d expense has grown by 10.6% (from $20.89 million to $23.11 million).
- The most recent figure is from Nanobiotix S.A.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: